Avid Bioservices Inc (CDMO)

[entdoc]

Most of the FDA required'heavy-lifting' for Bavi s done. Bavi being safe is huge. Not the whole enchilada, but safety is critical...do or die for a pharmaceutical upstart. Efficacy would have been nice too, but Bavi vs. advanced lung cancer? Not a chance. As an immunological adjust to chemotherapy? An oxymoron...non-sequitur? Note: Bavi + chemo is mostly what our options were back then. Safety opens vast new horizons for Bavi. Who can wait around for results of Bavi plus surgery for early stage disease? We want Bavi results NOW. No time for long-term outcome of Bavi +irradiation...and that is irradiation of almost any stage cancer. And do we have the time or money for the probable best place for Bavi? Given before, during, and/or after surgery...for almost any disease being approached surgically. Irrigate the wound with Bavi, etc. etc. Bali is absorbed through the nasal mucosa. Add it to your favorite nasal douche. I can understand why they have bothered with a Bavi trade name. Bali even has a new manufacturing plant ready to clone it. Now all we need is an application for Bavi, and I suspect that will happen. Think of all the myriad possibilities with Bavi. Curing advanced lung cancer with Bavi was a pipe-dream. The company got what it was after. If not efficacy, then at least information. Question is, will we stockholders be a part of the Bavi boom.